Covaxin human clinical trials to begin at AIIMS Delhi. All you need to know
Dr Sanjay Rai, Professor at the Centre for Community Medicine at AIIMS told ANI that the hospital will start enrolling healthy individuals from Monday onwards.
The All India Institute of Medical Sciences (AIIMS) in Delhi is scheduled to start phase I/II of human clinical trials of the indigenously developed Covid-19 vaccine candidate 'Covaxin' on Monday. AIIMS Delhi is among the 12 sites where human trials for Covaxin will be conducted.